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SUMMARY
Both left ventricular (LV) hypertrophy and insulin resistance (IR) have often been
demonstrated in patients with essential hypertension (EH). Insulin may exert a direct
growth promoting effect on cardiomyocytes rather than affecting the LV internal diame-
ter. The purpose of this study was to examine the effect of IR on LV geometry.
We enrolled 105 patients (71 females, mean age, 49.2 ± 13.6 years) with recently
diagnosed and untreated hypertension (blood pressure > 140 and/or 90 mmHg, fasting
glucose < 110 mg/dL), and grouped them as normal (N) (39 patients, 26 females, mean
age, 48.5 ± 14.7 years) if all M-mode echocardiographic measurements were within nor-
mal limits, concentric remodeling (CR) (22 patients, 15 females, mean age, 50.5 ± 14.8
years) if relative wall thickness was increased but left ventricular mass index (LVMI) was
normal, concentric hypertrophy (CH) (13 patients, 9 females, mean age, 50.3 ± 10.8
years) if both ventricular thicknesses and the LVMI were increased, and eccentric hyper-
trophy (EH) (31 patients, 21 females, mean age, 48.6 ± 12.9 years) if ventricular thick-
nesses were normal, but LVMI was increased. Transthoracic echocardiography was
performed in all subjects, and interventricular septal thickness (IVS), posterior wall thick-
ness (PWT), sum of wall thickness (SWT), left ventricular end-diastolic internal diameter
(LVED), relative wall thickness (RWT), and LVMI were recorded. Blood samples for
routine biochemical examination and fasting insulin levels were obtained and then the
homeostasis model assessment (HOMA) index was calculated by the formula: HOMA
Index = Fasting Blood Glucose (mg/dL) × Immunoreactive Insulin (µU/mL)/405, for the
assessment of IR.
There were no significant differences among the groups with respect to age, blood
pressure (BP) levels, fasting blood glucose (FBG), LDL-cholesterol (LDL-C), HDL-cho-
lesterol (HDL-C), total cholesterol (TC), or triglyceride (TG) levels. Insulin levels were
significantly higher in the CR and CH groups in comparison with the N group (P =
0.004), and the HOMA index was higher in the CH group compared to the N group (P =
0.024). In Pearson's correlation analysis, insulin was found to be directly correlated with
IVS (r = 0.29, P = 0.002), SWT (r = 0.25, P = 0.009), and RWT (r = 0.33, P = 0.0001).
The HOMA index was also directly correlated with IVS (r = 0.33, P = 0.001), SWT (r =
0.29, P = 0.002), and RWT (r = 0.29, P = 0.003).
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Cardiac changes in hypertensive patients include increased LVMI and altered LV
geometry. The concentric LV geometry seen in hypertensive patients might be mediated,
at least in part, by increased insulin levels and the HOMA index.  (Int Heart J 2006; 47: 
391-400)
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LEFT ventricular (LV) hypertrophy1-3) and hyperinsulinemia/insulin resistance4)
are well known independent cardiovascular risk factors. Experimental evidence
has also demonstrated that LV hypertrophy and insulin resistance are associated
with pathophysiologic findings.5-7) A wide spectrum of LV geometry has been
reported in general population samples and in patients with essential hyperten-
sion.8-10) Arterial hypertension represents, by itself, a fundamental stimulus for
the development of left ventricular hypertrophy (LVH). However, LV overload
imposed by arterial hypertension is more complex than expected, although in
some patients LV mass increases, while in others it remains within normal limits.
There is evidence that remodeling of the LV depends on the hemodynamic condi-
tions of preload, afterload, LV contractility state, and severity and duration of the
disease process.11,12) Hypertrophy secondary to pressure overload has a great
impact on the cardiovascular system and may develop with different patterns,
generically called ventricular geometries. The latter depend on the relationship
between wall thickness and ventricular cavity size. In the type known as “concen-
tric remodeling,” wall thickness predominates over ventricular cavity size; in
“eccentric hypertrophy,” the opposite relation takes place; and, finally, in “con-
centric hypertrophy,” both are increased. Ventricular mass is normal in the first
type and increased in the other two. Arterial hypertension is known as a long last-
ing chronic overload that induces important structural changes in the ventricular
myocardium.10) On the other hand, some nonhemodynamic factors13) such as
genetic,14,15) environmental,16) and metabolic factors have also been suggested to
affect LV mass and geometry. Among the metabolic factors, the presence of insu-
lin resistance (IR)17-19) has been found to be associated with LV growth. Most of
the methods to measure IR are not feasible to use in large populations because
they are expensive and time-consuming. Homeostasis model assessment
(HOMA) is a new method that allows an easy and inexpensive assessment of
IR.20) 
Accordingly, the present study was undertaken to assess the relationships
between plasma insulin levels and various parameters of LV structure and func-
tion in recently diagnosed hypertensive, nondiabetic patients not taking any anti-
hypertensive medication.
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METHODS
One hundred and five consecutive patients (71 females, 34 males, mean age,
49.2 ± 13.6 years) with newly diagnosed essential arterial hypertension (mean
arterial blood pressure; systolic, 150.9 ± 11.4 mmHg and diastolic, 99.4 ± 11.6
mmHg) were enrolled after informed written consent was obtained. Patients were
considered to be hypertensive according to their clinical blood pressure levels (≥
140 mmHg for systolic, and/or ≥ 90 mmHg for diastolic blood pressure as the
mean of 3 different measurements in at least 3 different visits at 1-week inter-
vals). Exclusion criteria from the study were a family history of diabetes and obe-
sity (BMI must be < 30 kg/m2), coronary artery disease, congestive heart failure,
valvular heart disease, impaired glucose tolerance, and diabetes mellitus. All
patients were free from cardiac medications and drugs known to interfere with
glucose metabolism and had a similar sedentary life style. The ethical committee
of our institution approved the study.
Blood samples were taken after at least 10 hours of overnight fasting to
determine fasting glucose and insulin levels. Fasting insulin concentrations were
measured by radioimmunoassay. In the same session, serum samples were with-
drawn to determine creatinine, fasting total cholesterol, high density lipoprotein
cholesterol (HDL-C), and triglyceride (TG) levels. HOMA was calculated for the
assessment of IR. The HOMA-index calculated by the formula according to the
method developed by Matthews, et al.20) is as follows:
Fasting Blood Glucose (mg/dL) × Fasting Immunoreactive Insulin (µU/mL)/405.
Echocardiographic studies were performed on each subject using a commer-
cially available Vivid 7 (General Electric) computed sonography system with 2.5
MHz transducer. The echocardiograms were obtained at rest with the subjects in
the left lateral decubitus position. Two-dimensional guided M-mode measure-
ments of left ventricular end-diastolic dimension (LVED), interventricular sep-
tum (IVS), and posterior wall thickness (PWT) were performed as recommended
by the American Society of Echocardiography.21) The sum of wall thickness was
calculated as the sum of IVS and PWT, while relative wall thickness (RWT) was
calculated as the ratio of the sum of wall thickness to left ventricular internal
dimension. Left ventricular mass (LVM) was calculated according to the regres-
sion equation of Devereux, et al: 0.80 × (1.04 × (LVED + IVS + PW)3 - (LVED)3)
+ 0.6 gm.22) LV mass was indexed by body surface area; LVH was defined as an
LV mass index (LVMI) of 125 g/m2 in men23) and 110 g/m2 in women.22) The
patients were grouped as normal (N) (39 patients, 26 females) if all the wall thick-
nesses and LVMI were within the normal limits, as concentric remodeling (CR)
(22 patients, 15 females) if RWT was increased (RWT ≥ 0.45)23) and LVMI was
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normal, as eccentric hypertrophy (EH) (31 patients, 21 females) if the opposite of
CR was observed, and finally, as concentric hypertrophy (CH) (13 patients, 9
females), if both were increased. The same physician, who was unaware of other
data relating to the subjects, made all the recordings.
Statistical analysis: All statistics were analysed using the SPSS 11.5 package
programme. Differences among the groups were analysed by one-way analysis of
variance followed by Tukey's test. The correlations among the HOMA index,
insulin levels, and LV measurements were investigated by Pearson correlation
analysis. A P value < 0.05 was regarded as being statistically significant.
RESULTS
We enrolled 105 patients (71 females, 34 males) with untreated recently
diagnosed mild-to-moderate hypertension (150.9 ± 11.4 mmHg for systolic, 99.4
± 11.6 mmHg for diastolic blood pressure). The patients were then classified as
normal (39 patients, 26 females), concentric remodelling (22 patients, 15
females), concentric hypertrophy (13 patients, 9 females), and eccentric hypertro-
phy (31 patients, 21 females) according to the echocardiographic measurements.
As shown in Table I, there were no differences concerning the clinical and meta-
bolic variables among the groups except for the fasting insulin and HOMA index
values, which were found to be significantly higher in the CR and CH groups for
the first, and higher in the CH group for the latter in comparison with the normal
group. Echocardiographic data for the groups are presented in Table II. As men-
Table I. Clinical and Metabolic Characteristics of Groups
Normal Concentricremodeling
Concentric
hypertrophy
Eccentric
hypertrophy P
Number
Age, years
Gender (female/male)
SBP, mmHg
DBP, mmHg
BMI, kg/m2 
Fasting glucose (mg/dL)
Fasting insulin, µU/mL
HOMA-index
TC (mg/dL)
TG (mg/dL)
HDL-C (mg/dL)
LDL-C (mg/dL)
39
48.5 ± 14.7
26/13
150.7 ± 11.4
99.7 ± 10.4
26.7 ± 3.1
95.5 ± 9.5
8.0 ± 1.9*
2.0 ± 0.8*
201.4 ± 33.6
146.6 ± 77.5
55.8 ± 13.3
114.7 ± 37.2
22
50.5 ± 14.8
15/7
151.3 ± 11.9
99.8 ± 11.3
26.4 ± 4.1
97.7 ± 9.3
12.2 ± 7.4*
2.4 ± 1.0
201.5 ± 24.5
159.2 ± 68.2
50.8 ± 10.0
126.0 ± 37.6
13
50.3 ± 10.8
9/4
151.5 ± 11.1
98.9 ± 12.5
26.1 ± 3.7
101.3 ± 16.5
13.0 ± 2.8*
3.1 ± 2.1*
219.3 ± 32.2
157.1 ± 118.7
51.5 ± 13.4
133.5 ± 48.2
31
48.6 ± 12.9
21/10
150.4 ± 12.1
99.9 ± 11.4
26.7 ± 3.2
94.9 ± 9.5
9.3 ± 2.8
2.2 ± 0.7
208.8 ± 30.5
139.5 ± 40.1
53.3 ± 10.5
129.5 ± 30.3
NS
NS
NS
NS
NS
NS
0.004
0.024
NS
NS
NS
NS
SBP indicates systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; 
HOMA-index, homeostasis model assessment; TC, total cholesterol; TG, triglycerides; HDL-C, 
high density lipoprotein cholesterol; and LDL-C, low density lipoprotein cholesterol. Values are 
mean ± SD, *: difference between normal and other groups.
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tioned above, all parameters were within normal limits in the N group, LVMI
increased in the CH and EH groups, RWT, SWT, and IVS measurements
increased in CR and CH, and LVED increased in the CH and EH groups, partic-
ularly the latter. Pearson's correlation analysis performed among the insulin lev-
els and echocardiographic measurements showed positive and significant
correlations between insulin levels and IVS (P = 0.002, r = 0.29), RWT (P =
0.0001, r = 0.33), and SWT (P = 0.009, r = 0.25), but no significant correlations
with the other echocardiographic data (Table III). Again Pearson's correlation
analysis was performed among the HOMA index and echocardiographic mea-
surements, and revealed significant positive correlations with IVS (P = 0.001, r =
0.33), RWT (P = 0.003, r = 0.29), and SWT (P = 0.002, r = 0.29), but no signifi-
cant correlations with the other echocardiographic data as shown in Table III.
There were no significant correlations between the HOMA index, insulin levels,
and body mass index (P = 0.9, 0.8), and systolic (P = 0.07, 0.08) or diastolic (P =
0.08, 0.1) blood pressures. The HOMA index values in the 4 different groups are
shown in Figure 1. It can be seen that the HOMA index was significantly higher
Table II. Echocardiographic Parameters of Groups
Normal Concentricremodeling
Concentric
hypertrophy
Eccentric
hypertrophy P
LVED (35-56 mm)
IVS (6.0-11 mm)
PWT (9.0-14 mm)
LVMI (g/m2)
RWT
SWT
46.5 ± 3.3
8.7 ± 1.1
8.0 ± 1.0
89.5 ± 16.6
0.37 ± 0.04
17.5 ± 1.8
42.5 ± 3.6
10.7 ± 1.1*
10.6 ± 1.3
88.0 ± 14.6
0.50 ± 0.04*
21.4 ± 1.4*
50.3 ± 3.0*
12.5 ± 1.6*
12.1 ± 1.3*
141.6 ± 19.4*
0.49 ± 0.04*
24.6 ± 2.0*
51.3 ± 4.4*
9.8 ± 1.4
9.9 ± 1.1
128.6 ± 23.7*
0.38 ± 0.05
19.5 ± 2.0
0.0001*
0.0001*
0.0001*
0.0001*
0.0001*
0.0001*
LVED indicates left ventricular end-diastolic diameter; IVS, interventricular septal thickness; 
PWT, posterior wall thickness; LVMI, left ventricular mass index; RWT, relative wall thick-
ness; and SWT, sum of wall thickness. *: significant difference with other groups.
Table III. Correlation Analysis Between Insulin, HOMA Index, and Echocardiographic
Variables
LVED IVS RWT LVMI PWT SWT
Insulin              r
P
HOMA index  r
P
−0.14
 0.13
−0.024
0.8
0.29
0.002
0.33
0.001
0.33
0.0001
0.29
0.003
0.016
0.87
0.15
0.11
0.13
0.17
0.16
0.08
0.25
0.009
0.29
0.002
LVED indicates left ventricular end-diastolic diameter; IVS, interventricular septal thickness; 
RWT, relative wall thickness; LVMI, left ventricular mass index; PWT, posterior wall thick-
ness; and SWT, sum of wall thickness.
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in the CH group compared to the normal group (P = 0.024). The correlations
between the HOMA index and SWT (P = 0.002, r = 0.29) and RWT (P = 0.003,
r = 0.29) are presented in Figure 2.
DISCUSSION
The correlations between measures of insulin resistance and left ventricular
Figure 1. Homeostasis model assessment index (HOMA) measures of groups. 
N indicates normal; CR, Concentric remodelling; CH, Concentric hypertrophy;
and EH, Eccentric hypertrophy.
* P = Significant in comparison with normal group.
A B
Figure 2. Correlation analysis between homeostasis model assessment index (HOMA) and sum of wall
thickness (SWT) (A), and relative wall thickness (RWT) (B).
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structure have been studied in different populations with varying results. Signifi-
cant relationships between insulin resistance and left ventricular mass have been
reported in hypertensive populations.24,25) However, other investigators have only
found a weak correlation between these parameters26) or no association at all27-29)
after adjustments for covariates. Our study confirms that in hypertensive patients,
there are correlations between LVMI, LV wall thicknesses, and IR, and they pro-
vide evidence that IVS, RWT, and SWT, but not the LVED, are the best echocar-
diographic parameters associated with fasting plasma insulin levels and the
HOMA index, which is an insulin resistance parameter. Furthermore, a change in
the echocardiographic patterns from normal to concentric hypertrophy, including
concentric remodeling, is associated with a trend towards insulin resistance.
Previous studies have concluded that LV hypertrophy indicates a worse
prognosis for hypertension.1-3) In fact, patients with increased LV mass have a
greater risk of cardiovascular and all cause mortality than those with lower LV
mass. Levy, et al1) also showed that this difference widened progressively over a
10-year follow-up, despite conventional antihypertensive therapy. Several but not
all studies23,30-33) have demonstrated a high risk of cardiovascular adverse events
in patients with concentric LV hypertrophy and a low risk in those with normal
LV geometry. Recent reports have demonstrated that the relationship between
wall thickness and chamber diameter is of importance with respect to cardiovas-
cular risk.22,34) A concentric left ventricular pattern characterized by high relative
wall thickness is associated with a poorer prognosis than eccentric hypertrophy in
which the ratio between wall thickness and chamber diameter is normal. Epide-
miological studies have shown that high fasting insulin levels are associated with
an adverse cardiovascular outcome, independent of other risk factors,34) and this
could be explained in part by a remodeling effect by insulin on left ventricular
structure. It has been proposed that insulin may exercise its influence on cardiac
geometry by acting as a growth factor35) and trophic effects by insulin on myocar-
dial tissue have been demonstrated in cell cultures36) and animal models.37) More-
over, it has been suggested that hyperinsulinemia stimulates sympathetic nervous
system (SNS) activity38) which may in turn affect ventricular structure directly,
due to growth-stimulating effects, or indirectly, by contributing to increases in
heart rate and blood pressure levels. Our study confirms the association of insulin
action and degree of LV mass and also shows that patients with a normal LV pat-
tern have a significantly better insulin action (lower fasting insulin levels and
lower HOMA index) than patients with abnormal LV geometry. However, no sig-
nificant differences among hypertensives with concentric remodeling and eccen-
tric or concentric hypertrophy were found.
Furthermore, BMI, systolic and diastolic arterial blood pressures, and both
LVM index and LVED had poor correlations with metabolic parameters, whereas
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SWT and RWT were significantly correlated positively with the fasting insulin
levels and HOMA index in correlation analysis. Such data support the hypothesis
that the reason for the increase in wall thickness, which is a sign of myocardial
structural change, and in part LV hypertrophy itself in hypertensive patients,
might be due to the increased fasting insulin levels and HOMA index, which is an
indicator of insulin resistance. Our data are in agreement with those of Bar-
bagallo, et al39) showing an increase in ventricular wall thickness in insulin-resis-
tant patients. Several pathophysiologic factors could be behind such an
association. An insulin-mediated overdrive in sympathetic nervous system
activity40) should be considered. The positive correlation between insulin levels
and the HOMA index were substantially stronger with SWT and RWT than the
LVM index. However, fasting insulin levels and the HOMA index were found to
be significantly higher in concentric remodeling and concentric hypertrophy
patients compared with the normal group. There were no differences between
eccentric hypertrophy and the other groups for those parameters. Therefore, we
can conclude that insulin acts through increases in wall thicknesses, rather than
an increase in LVED during the LV geometric change process in hypertensive
patients. Such an explanation may apply to these results. Another hypothesis is
SNS overdrive, which is responsible for both insulin resistance and development
of LVH.18) In fact, hypertensive patients with LVH had higher plasma catechola-
mine concentrations than hypertensive patients without LVH and control sub-
jects.7) Whether SNS activity can affect our data remains unknown. On the other
hand, our findings suggest that insulin resistance exerts its influence directly on
myocardial walls, independently of LVED. Hyperinsulinemia might increase LV
mass through its growth stimulating effect. In fact, insulin can bind and activate
the insulin-like growth factor-1 receptor, thus resulting in increased DNA and
protein synthesis as well as cell proliferation in many tissues.18,36) In particular, it
has been demonstrated that insulin stimulates the proliferation of vascular smooth
cells and induces the hypertrophy of cardiomyocytes by increasing mRNA levels
for muscle-specific genes (myosin light chain, O-actin, and troponin I) and stim-
ulating protein synthesis.40) Therefore, it is plausible that hyperinsulinemia in
hypertension could stimulate SNS activity, which may in turn affect ventricular
structure directly, due to growth-stimulating effects, or indirectly, by contributing
to increases in heart rate and blood pressure levels. However, further mechanistic
studies are required in order to clarify the links between insulin resistance, com-
pensatory hyperinsulinemia, and aberrations in cardiovascular structure.
In conclusion, cardiac changes in hypertensive people include increases in
left ventricular mass, as well as altered left ventricular geometry. The concentric
left ventricular geometry associated with hypertension appears to be mediated, at
least in part, by increased insulin levels, and the HOMA index. The present
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results might indicate that measurement of serum insulin levels and calculation of
the HOMA index could provide insights into the pathogenesis of different LV
geometries in patients with mild to moderate essential hypertension. 
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